Clinical trials in neuroprotection (Q37301629)

19 August 2017

1 reference

title

Clinical trials in neuroprotection (English)

1 reference

19 August 2017

1

Scott M Whitcup

1 reference

19 August 2017

1 January 2008

1 reference

Progress in Brain Research

19 August 2017

1 reference

19 August 2017

173

1 reference

19 August 2017

323-335

1 reference

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

19 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Ischaemic optic neuropathy. The clinical profile and history

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Clinical comparison of frequency doubling technology perimetry and Humphrey perimetry

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Frequency doubling technology perimetry for detection of glaucomatous visual field loss

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

From tau to toxicity: emerging roles of NMDA receptor in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

A "cure" for Parkinson's disease: can neuroprotection be proven with current trial designs?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Memantine in the treatment of mild-to-moderate Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Glutamate: A Neurotransmitter in Mammalian Brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Rates of change differ among measures of visual function in patients with retinitis pigmentosa

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

A comparison of the components of the multifocal and full-field ERGs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Recent developments in automated perimetry in glaucoma diagnosis and management.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Optic nerve sheath decompression for nonarteritic ischemic optic neuropathy improves multiple visual function measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Objective perimetry in glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

A comparison of short wavelength automated perimetry with frequency doubling perimetry for the early detection of visual field loss in ocular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Development of the 25-item National Eye Institute Visual Function Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Clinical ability of Heidelberg retinal tomograph examination to detect glaucomatous visual field changes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Results of the European Glaucoma Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--I. Anticonvulsant properties

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Molecular and biochemical features in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Abnormal glutamate metabolism in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Memantine in moderate-to-severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Clinical profile and long-term implications of anterior ischemic optic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Bias in analytic research

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Optic nerve decompression may improve the progressive form of nonarteritic ischemic optic neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Progressive and static nonarteritic ischemic optic neuropathy treated by optic nerve sheath decompression

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Optic nerve sheath decompression for the treatment of progressive nonarteritic ischemic optic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Identifying early glaucomatous changes. Comparison between expert clinical assessment of optic disc photographs and confocal scanning ophthalmoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

Discriminating between normal and glaucomatous eyes using the Heidelberg Retina Tomograph, GDx Nerve Fiber Analyzer, and Optical Coherence Tomograph

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2901123-0

7 January 2021

10.1016/S0079-6123(08)01123-0

Identifiers

DOI

1 reference

release_oeazrkmncfgphih6kx2zhbfdze

19 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/oeazrkmncfgphih6kx2zhbfdze

24 November 2022

mapped directly with Wikidata item

PubMed ID

18929119

1 reference

PubMed ID

18929119